Gray D. Shaw

9.2k total citations · 3 hit papers
52 papers, 8.0k citations indexed

About

Gray D. Shaw is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, Gray D. Shaw has authored 52 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Immunology and Allergy and 18 papers in Immunology. Recurrent topics in Gray D. Shaw's work include Cell Adhesion Molecules Research (19 papers), Organ Transplantation Techniques and Outcomes (15 papers) and Immune Response and Inflammation (8 papers). Gray D. Shaw is often cited by papers focused on Cell Adhesion Molecules Research (19 papers), Organ Transplantation Techniques and Outcomes (15 papers) and Immune Response and Inflammation (8 papers). Gray D. Shaw collaborates with scholars based in United States, Canada and United Kingdom. Gray D. Shaw's co-authors include Robert Kamen, Raymond T. Camphausen, Nicholas L. Tilney, W.S. Somers, Jin Tang, Kari C. Nadeau, Dianne Sako, K.M. Barone, Dale A. Cumming and M Takada and has published in prestigious journals such as Science, Cell and Nucleic Acids Research.

In The Last Decade

Gray D. Shaw

51 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation

1986 3.7k citations Gray D. Shaw, Robert Kamen Cell profile →
Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1

2000 612 citations W.S. Somers, Jin Tang et al. Cell profile →
Expression cloning of a functional glycoprotein ligand for P-selectin

1993 610 citations Dianne Sako, K.M. Barone et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gray D. Shaw United States	29	4.1k	2.2k	1.5k	1.0k	960	52	8.0k
Catherine Hession United States	33	4.0k 1.0×	3.3k 1.5×	1.7k 1.1×	702 0.7×	880 0.9×	49	9.6k
Lorenzo Silengo Italy	54	5.6k 1.4×	1.4k 0.6×	1.9k 1.3×	458 0.4×	895 0.9×	145	9.1k
Michiko N. Fukuda United States	55	6.3k 1.5×	2.8k 1.2×	925 0.6×	618 0.6×	550 0.6×	162	8.8k
Katherine A. Siminovitch Canada	52	3.6k 0.9×	4.2k 1.9×	1.2k 0.8×	626 0.6×	1.2k 1.3×	136	8.8k
Risto Renkonen Finland	38	2.5k 0.6×	1.5k 0.7×	1.4k 0.9×	489 0.5×	784 0.8×	195	5.2k
Manuel O. Landázuri Spain	47	2.7k 0.7×	2.8k 1.2×	1.2k 0.8×	325 0.3×	900 0.9×	109	6.9k
Peter J. Sims United States	50	4.6k 1.1×	3.3k 1.5×	653 0.4×	880 0.9×	557 0.6×	98	9.4k
Carl J. Kozlosky United States	18	3.1k 0.8×	2.1k 1.0×	1.4k 0.9×	293 0.3×	2.0k 2.1×	20	6.8k
Daniel C. Bullard United States	42	2.2k 0.5×	6.0k 2.7×	2.8k 1.9×	532 0.5×	1.2k 1.2×	94	9.5k
Luisa Lanfrancone Italy	38	4.9k 1.2×	1.2k 0.5×	503 0.3×	485 0.5×	1.6k 1.7×	95	7.8k

Countries citing papers authored by Gray D. Shaw

Since Specialization

Citations

This map shows the geographic impact of Gray D. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gray D. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gray D. Shaw more than expected).

Fields of papers citing papers by Gray D. Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gray D. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gray D. Shaw. The network helps show where Gray D. Shaw may publish in the future.

Co-authorship network of co-authors of Gray D. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Gray D. Shaw. A scholar is included among the top collaborators of Gray D. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gray D. Shaw. Gray D. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vats, Ravi, Egemen Tütüncüoğlu, Tirthadipa Pradhan‐Sundd, et al.. (2020). Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice. Experimental Hematology. 84. 1–6.e1. 6 indexed citations

Shaw, Gray D. & Robert Kamen. (2012). Pillars article: a conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986. 46: 659-667.. PubMed. 189(1). 5–13. 5 indexed citations

Tsuchihashi, Sei-ichiro, Constantino Fondevila, Gray D. Shaw, et al.. (2006). Molecular Characterization of Rat Leukocyte P-Selectin Glycoprotein Ligand-1 and Effect of Its Blockade: Protection from Ischemia-Reperfusion Injury in Liver Transplantation. The Journal of Immunology. 176(1). 616–624. 48 indexed citations

Swillo, Robert E., Courtney E. Leik, Jonathan Brooks, et al.. (2006). Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis. Thrombosis and Haemostasis. 95(3). 469–475. 35 indexed citations

Myers, Daniel D., John E. Rectenwald, Patricia W. Bedard, et al.. (2005). Decreased venous thrombosis with an oral inhibitor of P selectin. Journal of Vascular Surgery. 42(2). 329–336. 74 indexed citations

Gasser, Martin, Ana Maria Waaga-Gasser, Martin Grimm, et al.. (2005). Selectin Blockade Plus Therapy with Low-Dose Sirolimus and Cyclosporin A Prevent Brain Death-Induced Renal Allograft Dysfunction. American Journal of Transplantation. 5(4). 662–670. 19 indexed citations

Farmer, Douglas G., Xiu‐Da Shen, Farin Amersi, et al.. (2004). CD62 Blockade with P-Selectin Glycoprotein Ligand-Immunoglobulin Fusion Protein Reduces Ischemia-Reperfusion Injury After Rat Intestinal Transplantation. Transplantation. 79(1). 44–51. 29 indexed citations

Shaw, Gray D., Meng Li, Christopher L. Moore, et al.. (2002). CD62–PSGL-1 interactions regulate cytokine chemokine and apoptotic networks in cardiac allograft recipients. Transplantation Proceedings. 34(5). 1463–1464.

Amersi, Farin, Douglas G. Farmer, Gray D. Shaw, et al.. (2002). P‐Selectin Glycoprotein Ligand‐1 (rPSGL‐Ig)‐Mediated Blockade of CD62 Selectin Molecules Protects Rat Steatotic Liver Grafts from Ischemia/Reperfusion Injury. American Journal of Transplantation. 2(7). 600–608. 55 indexed citations

10.

Coito, Ana J., Gray D. Shaw, Jiye Li, et al.. (2002). Selectin-Mediated Interactions Regulate Cytokine Networks and Macrophage Heme Oxygenase-1 Induction in Cardiac Allograft Recipients. Laboratory Investigation. 82(1). 61–70. 26 indexed citations

11.

Farmer, Douglas G., Farin Amersi, Feng Gao, et al.. (2002). Improved survival through the reduction of ischemia-reperfusion injury after rat intestinal transplantation using selective P-selectin blockade with P-selectin glycoprotein ligand-Ig. Transplantation Proceedings. 34(3). 985–985. 16 indexed citations

12.

Gasser, Martin, Ana Maria Waaga, Joana E. Kist‐van Holthe, et al.. (2002). Normalization of Brain Death—Induced Injury to Rat Renal Allografts by Recombinant Soluble P-Selectin Glycoprotein Ligand. Journal of the American Society of Nephrology. 13(7). 1937–1945. 38 indexed citations

13.

Pratschke, Johann, Grzegorz Kofla, Markus J. Wilhelm, et al.. (2001). Improvements in Early Behavior of Rat Kidney Allografts After Treatment of the Brain-Dead Donor. Annals of Surgery. 234(6). 732–740. 83 indexed citations

14.

Somers, W.S., Gray D. Shaw, & Raymond T. Camphausen. (2001). Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1. Cell. 105(7). 971–971. 16 indexed citations

15.

Somers, W.S., Jin Tang, Gray D. Shaw, & Raymond T. Camphausen. (2000). Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1. Cell. 103(3). 467–479. 612 indexed citations breakdown →

16.

Goss, John A., David K. Imagawa, Gray D. Shaw, et al.. (1998). Reduction of Hepatic Ischemia/Reperfusion Injury by a Soluble P-Selectin Glycoprotein Ligand-1. Annals of Surgery. 227(6). 832–840. 97 indexed citations

17.

Takada, M, Kari C. Nadeau, Gray D. Shaw, Kimberly Marquette, & Nicholas L. Tilney. (1997). The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.. Journal of Clinical Investigation. 99(11). 2682–2690. 437 indexed citations

18.

Takada, Moriatsu, Kari C. Nadeau, Gray D. Shaw, & Nicholas L. Tilney. (1997). PREVENTION OF LATE RENAL CHANGES AFTER INITIAL ISCHEMIA/REPERFUSION INJURY BY BLOCKING EARLY SELECTIN BINDING1. Transplantation. 64(11). 1520–1525. 92 indexed citations

19.

Sako, Dianne, Kenneth M. Comess, K.M. Barone, et al.. (1995). A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell. 83(2). 323–331. 378 indexed citations

20.

Bagby, Grover C., Gray D. Shaw, & Gerald M. Segal. (1989). Human Vascular Endothelial Cells, Granulopoiesis, and the Inflammatory Response.. Journal of Investigative Dermatology. 93(s2). 48S–52S. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact